A randomized, double-blind comparison of risedronate and etidronate in the treatment of paget’s disease of bone
- 1 May 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 106 (5) , 513-520
- https://doi.org/10.1016/s0002-9343(99)00062-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The effects of intravenous alendronate in Paget's disease of boneJournal of Bone and Mineral Research, 1995
- Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's diseaseJournal of Bone and Mineral Research, 1995
- Paget's disease of bone treated with a five day course of oral tiludronate.Annals of the Rheumatic Diseases, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonateClinical Rheumatology, 1989
- Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of boneBone, 1988
- Treating Paget's disease.BMJ, 1987
- Skeletal Distribution and Biochemical Parameters of Paget??s DiseaseClinical Orthopaedics and Related Research, 1987
- Clinical and biochemical effects of EHDP in Paget's disease of bone: Patterns of response to initial treatment and to long-term therapyMetabolic Bone Disease and Related Research, 1981
- Long‐term therapy of paget's disease of bone with ehdpArthritis & Rheumatism, 1980